FDA Inspection 1236132 — Biodesix, Inc.

Biodesix, Inc. — FEI 3011854503

The FDA completed an inspection of Biodesix, Inc. on Apr 12, 2024 in Louisville, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 12, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Louisville, CO (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
310421 CFR 820.30(j)Design history file
313021 CFR 820.100(a)Lack of or inadequate procedures